Shattuck Labs, Inc. financial data

Symbol
STTK on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 W. 5 Th Street, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 914 % -1.75%
Debt-to-equity 13.7 % +2.78%
Return On Equity -68.7 % -25.1%
Return On Assets -60.4 % -24.8%
Operating Margin -2.2K % +80.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.7M shares +12.4%
Common Stock, Shares, Outstanding 47.7M shares +12.4%
Entity Public Float 85.6M USD -22.6%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 50.8M shares +19.6%
Weighted Average Number of Shares Outstanding, Diluted 50.8M shares +19.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.12M USD +380%
Research and Development Expense 74.9M USD -0.9%
General and Administrative Expense 19.7M USD -6.68%
Operating Income (Loss) -90.6M USD +5.59%
Net Income (Loss) Attributable to Parent -85.3M USD +7.42%
Earnings Per Share, Basic -1.85 USD/shares +14.7%
Earnings Per Share, Diluted -1.85 USD/shares +14.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 60.7M USD -15.6%
Cash, Cash Equivalents, and Short-term Investments 105M USD -10.2%
Assets, Current 114M USD -16.1%
Property, Plant and Equipment, Net 11.9M USD -25.7%
Operating Lease, Right-of-Use Asset 2.27M USD -13.8%
Other Assets, Noncurrent 2.29M USD -18.2%
Assets 129M USD -17.2%
Accounts Payable, Current 2.82M USD +40.3%
Employee-related Liabilities, Current 2.78M USD +18.2%
Contract with Customer, Liability, Current 3M USD +303%
Liabilities, Current 15M USD +15.6%
Operating Lease, Liability, Noncurrent 2.97M USD -22.2%
Liabilities 18M USD +7.05%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5K USD +93.2%
Retained Earnings (Accumulated Deficit) -346M USD -32.7%
Stockholders' Equity Attributable to Parent 111M USD -20.1%
Liabilities and Equity 129M USD -17.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.2M USD +38.9%
Net Cash Provided by (Used in) Financing Activities -184K USD
Net Cash Provided by (Used in) Investing Activities -33.3M USD -174%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 47.7M shares +12.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -49.6M USD -366%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 60.7M USD -15.6%
Deferred Tax Assets, Valuation Allowance 76.4M USD +38.8%
Deferred Tax Assets, Gross 77.9M USD +37.4%
Operating Lease, Liability 4.2M USD -14.3%
Depreciation 974K USD -3.95%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -85.2M USD +6.44%
Lessee, Operating Lease, Liability, to be Paid 5.09M USD -17.6%
Property, Plant and Equipment, Gross 23.3M USD -0.3%
Operating Lease, Liability, Current 847K USD +13.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.15M USD +2.86%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.12M USD +2.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 884K USD -30.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.09M USD -5.12%
Deferred Tax Assets, Operating Loss Carryforwards 31.4M USD +26.2%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.26M USD +36.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 848K USD -22.4%
Operating Lease, Payments 200K USD
Additional Paid in Capital 457M USD +14.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.55M USD -6.67%
Share-based Payment Arrangement, Expense 8.55M USD +22.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%